Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells

Biochem Biophys Res Commun. 1996 May 24;222(3):694-9. doi: 10.1006/bbrc.1996.0806.

Abstract

Mucinous colorectal cancers have a poorer prognosis than colorectal cancers which produce a low amount of mucin, but the exact mechanism is not well understood. The present study was undertaken to elucidate the possible mechanisms of invasion and metastasis of colon cancer cells producing high levels of mucin using mucin glycosylation inhibitor, benzyl-alpha-N-acetylgalactosamine. The binding activity of treated HM7 cells to endothelial leukocyte adhesion molecule (ELAM-1) was significantly decreased and fixed cell binding of MoAb SNH-3 and 19-9 (specific for sialyl Le(x) and sialyl Le(a), respectively) was also significantly decreased. Metalloproteinase activity in conditioned medium and invasion of matrigel-coated porous filters by treated HM7 cells were decreased. However, there was no difference between control and treated HM7 cells in terms of matrix protein binding. These results suggest that O-glycosylated mucin is important in the invasive and metastatic properties of HM7 human colon cancer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylgalactosamine / analogs & derivatives
  • Acetylgalactosamine / pharmacology
  • Benzyl Compounds / pharmacology
  • Colonic Neoplasms / pathology*
  • E-Selectin / metabolism
  • Glycosylation
  • Humans
  • Membrane Glycoproteins / metabolism
  • Metalloendopeptidases / metabolism
  • Mucins / chemistry*
  • Mucins / metabolism
  • Mucins / physiology
  • Neoplasm Invasiveness*
  • Neoplasm Metastasis*
  • Tumor Cells, Cultured
  • Urokinase-Type Plasminogen Activator / metabolism

Substances

  • Benzyl Compounds
  • E-Selectin
  • Membrane Glycoproteins
  • Mucins
  • benzyl-alpha-N-acetylgalactosamine
  • Urokinase-Type Plasminogen Activator
  • Metalloendopeptidases
  • Acetylgalactosamine